| Conclusions: Even though the reduction in metastasis at the time of diagnosis seen in the present study is a prerequisite for a successful prostate cancer-screening program, the ultimate outcome in the screening studies is a difference in prostate cancer mortality. As the very large combined screening efforts (ERSPC and PLCO trials) are to be analyzed regarding survival in 2008, we strongly suggest that decisions regarding large-scale screening efforts are deferred pending these reports. |
This was already a well accepted position. I agree that the important thing will be to see if it can be proven to lower mortality.